Critical difference: Compounded semaglutide does not undergo the same extensive stability testing as FDA-approved products
Practical strategies include eating small, frequent meals, favoring low-fat bland foods, using ginger as an adjunctive remedy, and modifying fluid timing around meals
However, the landmark SURMOUNT-5 trial (published in mid-2025), which compared the two medications head-to-head, clarified the clinical reality: Total Weight Loss: Tirzepatide drives significantly greater total weight loss (averaging over 20%) compared to semaglutide (averaging roughly 14%)
Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials
It is the only Semaglutide pill approved for adults with T2DM, providing a convenient and effective solution for managing blood sugar levels, aiding in weight loss , and reducing the risk of chronic kidney disease and major cardiovascular events
Ensure adequate calcium and vitamin D intake
